Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Neuroimage|September 27, 2008
Test-retest reliability of EEG spectra during a working memory taskMarkus Näpflin, Marc Wildi, Johannes Sarnthein
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|September 26, 2007
Test-retest reliability of resting EEG spectra validates a statistical signature of personsMarkus Näpflin, Marc Wildi, Johannes Sarnthein
Patient Preference and Adherence|November 26, 2020
Continuity of Care in Swiss Cancer Patients Using Claims DataEva Blozik, Caroline Bähler, Markus Näpflin, et al.
European Journal of Public Health|April 8, 2023
Continuity of care and treatment intensity at the end of life in Swiss cancer patientsCaroline Bähler, Markus Näpflin, Martin Scherer, et al.
Pharmacoepidemiology and Drug Safety|December 13, 2019
Pharmaceutically treated comorbidities and associated healthcare costs among triptan users in Switzerland: A pharmacoepidemiological study from a nationwide health insurance databaseCarola A Huber, Reto Agosti, Markus Näpflin, et al.
BMC Health Services Research|February 27, 2022
Does hospital volume affect outcomes after abdominal cancer surgery: an analysis of Swiss health insurance claims dataKevin Wirth, Markus Näpflin, Sereina M Graber, et al.
Journal of Pain Research|August 16, 2019
Treatment patterns in patients using triptan and prophylactic medication: an analysis of clinical practice prior to the introduction of CGRP antagonistsCarola A Huber, Reto Agosti, Markus Näpflin, et al.
Diagnostics (Basel, Switzerland)|November 14, 2023
Are Tumor Marker Tests Applied Appropriately in Clinical Practice? A Healthcare Claims Data AnalysisSabrina M Stollberg, Markus Näpflin, Michael Nagler, et al.
BMJ Open|November 21, 2023
Initial prescriptions and medication switches of biological products: an analysis of prescription pathways and determinants in the Swiss healthcare settingKevin Wirth, Stefan Boes, Markus Näpflin, et al.
JMIR Public Health and Surveillance|January 8, 2025
Trends in Prescription of Stimulants and Narcoleptic Drugs in Switzerland: Longitudinal Health Insurance Claims Analysis for the Years 2014-2021Tamara Scharf, Carola A Huber, Markus Näpflin, et al.
Pageof 2